Stage II Breast Cancer Completed Phase 2 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00194779Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryTreatment
NCT00407888Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With SurgeryTreatment
NCT00049114Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast CancerTreatment
NCT00119262Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerTreatment